Center-Authored Papers

Filters: Keyword is Confounding Factors (Epidemiology)  [Clear All Filters]
A
Albain KS, Unger JM, Crowley J, Coltman CA, Hershman DL.  2009.  Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.. Journal of the National Cancer Institute. 101(14):984-92. Abstract
Asgari MM, Maruti SS, White E.  2008.  A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.. Journal of the National Cancer Institute. 100(13):967-71. Abstract
B
Beasley JM, LaCroix AZ, Neuhouser ML, Huang Y, Tinker L, Woods N, Michael Y, Curb DJ, Prentice RL.  2010.  Protein intake and incident frailty in the Women's Health Initiative observational study.. Journal of the American Geriatrics Society. 58(6):1063-71. Abstract
Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB et al..  2010.  Body-mass index and mortality among 1.46 million white adults.. The New England journal of medicine. 363(23):2211-9. Abstract
Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B et al..  2008.  Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.. Journal of the National Cancer Institute. 100(1):32-40. Abstract
C
Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD et al..  2010.  Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status.. Journal of the National Cancer Institute. 102(6):391-400. Abstract
Chang S, Long SR, Kutikova L, Bowman L, Crown WH, Lyman GH.  2006.  Burden of pancreatic cancer and disease progression: economic analysis in the US.. Oncology. 70(1):71-80. Abstract
Chlebowski RT, Prentice RL.  2008.  Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.. Journal of the National Cancer Institute. 100(19):1341-3.
F
Friedman DL, Whitton J, Leisenring WM, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP.  2010.  Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.. Journal of the National Cancer Institute. 102(14):1083-95. Abstract
H
Heck JE, Berthiller J, Vaccarella S, Winn DM, Smith EM, Shan'gina O, Schwartz SM, Purdue MP, Pilarska A, Eluf-Neto J et al..  2010.  Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium.. International journal of epidemiology. 39(1):166-81. Abstract
J
Janes H, Sheppard L, Shepherd K.  2008.  Statistical analysis of air pollution panel studies: an illustration.. Annals of epidemiology. 18(10):792-802. Abstract
L
Lyman GH, Culakova E, Griggs J.  2004.  Use of antibiotics and risk of cancer.. JAMA : the journal of the American Medical Association. 291(22):2700;authorreply2700.
Lyman GH, Kuderer NM, Freedland SJ.  2009.  Does treatment intensity matter in superficial bladder cancer? Consensus, clinical practice, and confounding. Journal of the National Cancer Institute. 101(8):543-5.
Lyman GH, Peppercorn J.  2009.  Isolated tumor cells in breast cancer.. The New England journal of medicine. 361(20):1994;authorreply1995-6.
M
Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, Gail MH.  2011.  Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women.. Journal of the National Cancer Institute. 103(12):951-61. Abstract
O
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
R
Rossing MA, Wicklund KG, Cushing-Haugen KL, Weiss NS.  2010.  Predictive value of symptoms for early detection of ovarian cancer.. Journal of the National Cancer Institute. 102(4):222-9. Abstract
Rubinstein L, LeBlanc M, Smith MA.  2011.  More randomization in phase II trials: necessary but not sufficient.. Journal of the National Cancer Institute. 103(14):1075-7.
T
Tang JY, Spaunhurst KM, Chlebowski RT, Wactawski-Wende J, Keiser E, Thomas F, Anderson ML, Zeitouni NC, Larson JC, Stefanick ML.  2011.  Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.. Journal of the National Cancer Institute. 103(19):1469-75. Abstract
Z
Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, Lin DW.  2011.  Influence of publication of US and European prostate cancer screening trials on PSA testing practices.. Journal of the National Cancer Institute. 103(6):520-3. Abstract